Surveillance is recommended for patients with chronic inflammatory bowel disease (IBD), as they have an increased risk of colorectal cancer (CRC). According to recent study data, published in Clinical Gastroenterology and Hepatology, the incidence of interval colorectal cancers, (cancers occurring between scheduled surveillance colonoscopies), is low in patients undergoing regular surveillance colonoscopy. Dr. John Kisiel, M.D., explains how current surveillance guidelines may impact interval CRC.
Dr. Kisiel underscores two important facts:
Read the full study online here.
For more information about IBD, visit mayoclinic.org/ibd.
Dr. Kisiel is a gastroenterologist at Mayo Clinic.